𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Applying proteomics to the diagnosis and treatment of ALS and related diseases

✍ Scribed by Robert Bowser; David Lacomis


Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
122 KB
Volume
40
Category
Article
ISSN
0148-639X

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Protein‐based biomarkers for amyotrophic lateral sclerosis (ALS) and other motor neuron diseases (MNDs) have many potential clinical utilities, including diagnostic, prognostic, and drug development indications. During the past decade a number of potential protein biomarkers have been proposed for MNDs. Further verification studies, followed by large validation and qualification studies, are required to advance these initial discoveries toward clinical use. Study of additional patient populations, including disease mimics, is required during the validation phase of biomarker development. Important regulatory issues are discussed that will affect the timing and strategy for biomarker assay development in ALS and other MNDs. The continued development of protein biomarkers for MNDs requires extensive collaboration between academic clinicians and scientists in conjunction with the biotechnology and pharmaceutical industries. Muscle Nerve, 2009


πŸ“œ SIMILAR VOLUMES


Issues related to the diagnosis and trea
✍ Shattuck, Paul T. ;Grosse, Scott D. πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 142 KB

## Abstract This paper explores issues and implications for diagnosis and treatment, stemming from the growing number of children identified with autism spectrum disorders (ASDs). Recent developments and innovations in special education and Medicaid programs are emphasized. Eligibility determinatio

Redox Proteomics (From Protein Modificat
✍ Dalle-Donne, Isabella; Scaloni, Andrea; Butterfield, D. Allan πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley & Sons, Inc. 🌐 English βš– 536 KB

methodology And Applications Of Redox Proteomics The Relatively New And Rapidly Changing Field Of Redox Proteomics Has The Potential To Revolutionize How We Diagnose Disease, Assess Risks, Determine Prognoses, And Target Therapeutic Strategies For People With Inflammatory And Aging-as

Diagnosis and treatment of complications
✍ JosΓ© Fidel Baizabal Carvallo; Richard Simpson; Joseph Jankovic πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 367 KB

## Abstract Deep brain stimulation is a therapeutic technique increasingly used in the treatment of a variety of neurological, psychiatric, and pain disorders. Although beneficial, it carries the immediate and long‐term risks associated with implanted hardware in the brain parenchyma and subcutaneo

Novel tools for extraction and validatio
✍ Remko Kuipers; Tom van den Bergh; Henk-Jan Joosten; Ronald H. Lekanne dit Deprez πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 333 KB

Genetic disorders are often caused by nonsynonymous nucleotide changes in one or more genes associated with the disease. Specific amino acid changes, however, can lead to large variability of phenotypic expression. For many genetic disorders this results in an increasing amount of publications descr